Emma reports H1 revenue growth; on target to hit €800m sales

Mattress brand Emma – The Sleep Company has continued its impressive growth story in the first half of 2022, with a year-on-year revenue growth rate of 33%.

Emma increased its half-year revenues to EUR 386 million in the first six months of 2022, compared to EUR 291 million in H1 2021. The sleep brand forecasts annual turnover of at least EUR 800 million by the end of 2022, which will be Emma’s fifth consecutive financial year of profitability and growth.

“We couldn’t be happier about our performance so far in 2022. Even in this challenging economic climate, where the volume in our industry has dropped by around 30 per cent in many countries, we have continued to grow profitability and look set to exceed a record EUR 800 million in revenue this year. From day one, we have been incredibly focused and motivated on having a profitable, viable business model and this is paying dividends now,” said Dr Dennis Schmoltzi, Co-founder and CEO of Emma – The Sleep Company.

Emma’s expansion into more than 30 markets in recent years paid off and contributed to the company’s buoyant H1 performance, enjoying strong growth in Europe, the Americas and Asia-Pacific.

Six of Emma’s European markets experienced a growth rate of higher than 40% in the first half of the year: France, the Netherlands, Austria, Italy, Sweden and Poland.

“To support further growth, we will continue to expand. The next step is the opening of an office in Bucharest in Q4 22 to attract the right talent and meet our headcount needs,” said Manuel Mueller, Co-founder and CEO of Emma – The Sleep Company.

“Our expansion into Asia-Pacific and Americas was an important milestone and it is now evident that these countries are contributing to the company’s rapid growth. Markets like the Philippines, Taiwan, Colombia and Canada are registering the highest growth rates in the company.”

Save this article for later

You can revisit this article if you save it as favourite news!

Leave a Comment

MORE ARTICLES